Long Term Testosterone Therapy Improves Metabolic Syndrome & Reduces Heart Disease (study)
In October of 2013, the International Journal of Clinical Practice published, “Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study”. In this study, 255 men ages 33-55 with low testosterone and symptoms of low testosterone, were treated and followed for up to 60 months. You can read the study here…
The results showed the following average changes:
- Total cholesterol dropped from 281 to 188.
- LDL dropped from164 to 110.
- CRP dropped from 6.29 to 1.03.
There were also marked reductions in systolic and diastolic blood pressures, blood glucose, HgA1c, and the liver functions creating alanine aminotransferase and aspartate aminotransferase.
With these BIG health benefits being seen in so many important health parameters by the simple normalization of testosterone for testosterone deficient men, it is time this treatment be offered to all men suffering from low testosterone. The health impact will be huge.